294 related articles for article (PubMed ID: 22941225)
1. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity.
Rodriguez FJ; Perry A; Rosenblum MK; Krawitz S; Cohen KJ; Lin D; Mosier S; Lin MT; Eberhart CG; Burger PC
Acta Neuropathol; 2012 Nov; 124(5):627-41. PubMed ID: 22941225
[TBL] [Abstract][Full Text] [Related]
2. Diffuse leptomeningeal neuroepithelial tumor: 9 pediatric cases with chromosome 1p/19q deletion status and IDH1 (R132H) immunohistochemistry.
Schniederjan MJ; Alghamdi S; Castellano-Sanchez A; Mazewski C; Brahma B; Brat DJ; Brathwaite CD; Janss AJ
Am J Surg Pathol; 2013 May; 37(5):763-71. PubMed ID: 23588371
[TBL] [Abstract][Full Text] [Related]
3. Anaplastic oligodendroglioma with ganglioglioma-like maturation.
Tanaka Y; Nobusawa S; Yagi S; Ikota H; Yokoo H; Nakazato Y
Brain Tumor Pathol; 2012 Oct; 29(4):221-8. PubMed ID: 22231405
[TBL] [Abstract][Full Text] [Related]
4. Oligodendroglial tumors with marked desmoplasia: clinicopathologic and molecular features of 7 cases.
Jentoft M; Giannini C; Rossi S; Mota R; Jenkins RB; Rodriguez FJ
Am J Surg Pathol; 2011 Jun; 35(6):845-52. PubMed ID: 21552114
[TBL] [Abstract][Full Text] [Related]
5. Primary disseminated leptomeningeal oligodendroglioma with 1p deletion. Case report.
Bourne TD; Mandell JW; Matsumoto JA; Jane JA; Lopes MB
J Neurosurg; 2006 Dec; 105(6 Suppl):465-9. PubMed ID: 17184079
[TBL] [Abstract][Full Text] [Related]
6. Primary leptomeningeal oligodendroglioma with documented progression to anaplasia and t(1;19)(q10;p10) in a child.
Rossi S; Rodriguez FJ; Mota RA; Dei Tos AP; Di Paola F; Bendini M; Agostini S; Longatti P; Jenkins RB; Giannini C
Acta Neuropathol; 2009 Oct; 118(4):575-7. PubMed ID: 19562354
[No Abstract] [Full Text] [Related]
7. Paediatric diffuse leptomeningeal tumor with glial and neuronal differentiation harbouring chromosome 1p/19q co-deletion and H3.3 K27M mutation: unusual molecular profile and its therapeutic implications.
Nambirajan A; Suri V; Kedia S; Goyal K; Malgulwar PB; Khanna G; Panda PK; Gulati S; Garg A; Sharma MC
Brain Tumor Pathol; 2018 Jul; 35(3):186-191. PubMed ID: 30030640
[TBL] [Abstract][Full Text] [Related]
8. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
[TBL] [Abstract][Full Text] [Related]
9. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
Weller M; Berger H; Hartmann C; Schramm J; Westphal M; Simon M; Goldbrunner R; Krex D; Steinbach JP; Ostertag CB; Loeffler M; Pietsch T; von Deimling A;
Clin Cancer Res; 2007 Dec; 13(23):6933-7. PubMed ID: 18056167
[TBL] [Abstract][Full Text] [Related]
10. Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas.
Kreiger PA; Okada Y; Simon S; Rorke LB; Louis DN; Golden JA
Acta Neuropathol; 2005 Apr; 109(4):387-92. PubMed ID: 15739101
[TBL] [Abstract][Full Text] [Related]
11. [Influence of molecular-genetic factors on prognosis in patients with oligodendroglial tumors].
Absaliamova OV; Korshunov AG; Loshakov VA; Kobiakov GL; Golanov AV; Urakov SV; Amanov RD; Lichinitser MR
Zh Vopr Neirokhir Im N N Burdenko; 2009; (1):17-23; discussion 23-4. PubMed ID: 19507310
[TBL] [Abstract][Full Text] [Related]
12. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
13. [Glioneuronal tumor with neuropil-like island: report of four cases and review of literature].
Duan ZJ; Yao K; Qi XL
Zhonghua Bing Li Xue Za Zhi; 2016 May; 45(5):324-8. PubMed ID: 27142914
[TBL] [Abstract][Full Text] [Related]
14. Utility of in situ demonstration of 1p loss and p53 overexpression in pathologic diagnosis of oligodendroglial tumors.
Hirose T; Ishizawa K; Shimada S
Neuropathology; 2010 Dec; 30(6):586-96. PubMed ID: 20408960
[TBL] [Abstract][Full Text] [Related]
15. Primary leptomeningeal anaplastic oligodendroglioma with a 1p36-19q13 deletion: report of a unique case successfully treated with Temozolomide.
Michotte A; Chaskis C; Sadones J; Veld PI; Neyns B
J Neurol Sci; 2009 Dec; 287(1-2):267-70. PubMed ID: 19751941
[TBL] [Abstract][Full Text] [Related]
16. The impact of molecular and clinical factors on patient outcome in oligodendroglioma from 20 years' experience at a single centre.
Parkinson JF; Afaghi V; Payne CA; Buckland ME; Brewer JM; Biggs MT; Little NS; Wheeler HR; Cook RJ; McDonald KL
J Clin Neurosci; 2011 Mar; 18(3):329-33. PubMed ID: 21247767
[TBL] [Abstract][Full Text] [Related]
17. Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features.
Jenkinson MD; du Plessis DG; Smith TS; Joyce KA; Warnke PC; Walker C
Brain; 2006 Jul; 129(Pt 7):1884-91. PubMed ID: 16670176
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component.
Takeuchi H; Kubota T; Kitai R; Matsuda K; Hashimoto N; Sato K
J Neurooncol; 2009 Jan; 91(1):33-8. PubMed ID: 18781279
[TBL] [Abstract][Full Text] [Related]
19. Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p/19q deletion analysis.
Barbashina V; Salazar P; Ladanyi M; Rosenblum MK; Edgar MA
Am J Surg Pathol; 2007 Aug; 31(8):1196-202. PubMed ID: 17667543
[TBL] [Abstract][Full Text] [Related]
20. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
Preusser M; Budka H; Rössler K; Hainfellner JA
Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
